MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present primary endpoint and 6-month data from its DESyne BDS Plus Randomized Clinical Trial (RCT), a prospective, multicenter, single-blind study, as part of The Innovation Program at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. The data […]
Coronary/Structural Heart
Millar to Unveil Revolutionary Chronic Pressure Measurement Platform at MD&M Minneapolis
HOUSTON, Oct. 5, 2023 /PRNewswire/ — Millar, OEM solutions partner and leader in MEMS pressure sensor integration, is thrilled to announce that it will officially unveil its groundbreaking chronic pressure measurement technology platform, TiSense, at the upcoming MD&M tradeshow in Minneapolis on October 10-11, 2023. This event serves as the perfect stage for Millar to introduce TiSense […]
Elixir Medical Completes Submission of DynamX Coronary Bioadaptor System to Japan’s PMDA Agency for Regulatory Approval
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the approval of the DynamX® Coronary Bioadaptor System for the treatment of coronary artery disease (CAD). DynamX coronary bioadaptor was developed to overcome the limitations of drug-eluting stents (DES) and […]
FineHeart Obtains Czech Health Authority Approval to Commence First in Human Clinical Study
BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a medical device company developing innovative devices for cardiology announced today that it has received authorization from the SUKL (the Czech Republic State Institute for the Control of Medicinal Products) to carry out “A prospective, single arm, single center, First in Human Study to evaluate the […]
SS Innovations Launches Innovative Robotic Cardiac Surgery Program in India
FORT LAUDERDALE, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the launch of an innovative robotic cardiac surgery program […]
FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal Syndrome
DENVER, Sept. 29, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces receipt of U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its patented, first-in-class, cell-directed Selective Cytopheretic Device (SCD) for use with patients in the hospital […]
Cardiost, Inc. Strengthens Scientific Advisory Board with Renowned Cardiovascular Experts, Advances Prototype Development with OEDIT Grant Support
Fort Collins, CO, Sept. 29, 2023 (GLOBE NEWSWIRE) — Fort Collins, CO – Colorado-based medical device start-up Cardiost, Inc., a graduate of Innosphere Ventures Accelerator program, has added key opinion leaders Dr. Daniel J. Goldstein, MD and Dr. Pedro R. Moreno, MD as part of their Scientific Advisory Board. Cardiost is currently designing an alpha prototype […]
AccuLine Announces Know-How License Agreement with Mayo Clinic to Advance Early Detection of Heart Attacks
PETAH-TIKVA, Israel, Sept. 28, 2023 /PRNewswire/ — AccuLine, a digital health startup company, has announced today a collaboration with Mayo Clinic through a know-how license agreement for the advancement of CORA, AccuLine’s novel solution designed for the early detection of coronary artery disease (CAD). As part of the agreement, Mayo Clinic will become a shareholder in […]
Clint and ACC Collaborate on Innovations to Advance Precision Health and Expand Access to Clinical Trials
Redwood City, California, Sept. 28, 2023 (GLOBE NEWSWIRE) — Clint, the clinical intelligence platform, is collaborating with the American College of Cardiology to advance precision health and expand access to clinical trials. This collaboration will accelerate time-to-market for novel therapies and support clinicians in identifying and closing care gaps for each individual patient […]
Nanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs
NEVE ILAN, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that HealthCCSng, an AI-powered solution created by Nanox’s deep-learning medical imaging analytics subsidiary, Nanox.AI, was used in a clinical study evaluating routine CT scans and found that […]
